The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AEGLEA BIOTHERAPEUTICS INC | COM | 00773J103 | 2,587 | 279,678 | SH | SOLE | 0 | 279,678 | 0 | 0 | |
AMGEN INC | COM | 031162100 | 853 | 3,615 | SH | SOLE | 0 | 3,615 | 0 | 0 | |
APOLLO ENDOSURGERY INC | COM | 03767D108 | 456 | 279,037 | SH | SOLE | 0 | 279,037 | 0 | 0 | |
LEXICON PHARMACEUTICALS INC | COM | 528872302 | 71 | 35,714 | SH | SOLE | 0 | 35,714 | 0 | 0 | |
PLX PHARMA INC | COM | 72942A107 | 203 | 62,673 | SH | SOLE | 0 | 62,673 | 0 | 0 | |
PORTLAND GENERAL ELECTRIC CO | COM | 736508847 | 5 | 118 | SH | SOLE | 0 | 118 | 0 | 0 | |
SOLITON INC | COM | 834251100 | 3,307 | 425,000 | SH | SOLE | 0 | 425,000 | 0 | 0 | |
SQUARE INC | COM | 852234103 | 52 | 500 | SH | SOLE | 0 | 500 | 0 | 0 | |
STRYKER CORP | COM | 863667101 | 685 | 3,800 | SH | SOLE | 0 | 3,800 | 0 | 0 | |
TEXAS INSTRUMENTS INC | COM | 882508104 | 4,063 | 32,000 | SH | SOLE | 0 | 32,000 | 0 | 0 | |
VANGUARD TOTAL WORLD STOCK ETF | ETFS | 922042742 | 13,581 | 181,558 | SH | SOLE | 0 | 181,558 | 0 | 0 |